“…MATERIALS AND METHODS: We retrospectively reviewed the medical records of patients with a first recurrence of cervical cancer (stage IB2–IVA), who were initially treated with CCRT and completed the planned radiotherapy from 2002 to 2018. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The patient, a 72‐year‐old Japanese woman, was diagnosed as having stage IVA lung adenocarcinoma because she had multiple nodules in both lungs. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…We report a sixty-seven-old year man diagnosed with adenocarcinoma T1cN3M1a, stage IVA. Initial screening performed 7 years earlier using EGFR mutation and ALK immunohistochemical tests were negative. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Our patient was diagnosed with stage IVA vaginal squamous cell carcinoma, based on a gynecological examination, colposcopy biopsy with histopathological examination, computed tomography scan, and tumor marker levels by two professors. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Based on the tentative identification and semi-quantification, the amounts of five ginsenosides (i.e., notoginsenoside H, glucoginsenoside Rf, notoginsenoside R1, pseudoginsenoside RT2, and ginsenoside Rc) were 2.3–54.5 fold greater in wild ginseng in comparison to those in their cultivated counterparts, and the content of six ginsenosides (chicusetsusaponin IVa, malonylginsenoside Rd, pseudoginsenoside Rc1, malonylfloralginsenoside Rd6, Ginsenoside Rd, and malonylginsenoside Rb1) was 2.6–14.4 fold greater in cultivated ginseng compared to wild ginseng. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Finally, we used AssemblyTron to perform site-directed mutagenesis reactions via homology-dependent IVA also achieving comparable fidelity to manual assemblies as assessed by sequencing. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Bilateral involvement of the lungs indicated stage IVa squamous cell lung cancer, which is not curable. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Phylogenetic analysis of DENV-2 sequenced samples (n = 8) revealed a monophyletic clade of cosmopolitan genotype IVA, which is closely related to sequences from China and Singapore 2018, and DENV-1 samples (n = 2) show genotype III, which is closely related to Pakistan isolates from 2019. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Acetylcholinesterase, phospholipase A2 group IIA, and phospholipase A2 group IVA may be the most promising therapeutic targets. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Imaging examination revealed a mass in the middle and lower lobes of the right lung invading the right pulmonary artery and metastases to the right hilar lymph nodes and pleura. A stage IVa (cT4N1M1a) lung adenocarcinoma with ALK fusion was diagnosed. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: We retrospectively reviewed 58 patients who underwent laparoscopic surgery for hepatic hemangioma at a single center from January 2016 to January 2022. Segments I, IVa, VII, and VIII are defined as special hepatic segments, attributing to the bad visualization and adjacent to important vessels such as hepatic veins and inferior vena cava that lead to a high risk in laparoscopic surgery. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…DIAGNOSIS: The patient was eventually diagnosed with nasopharyngeal nonkeratinizing undifferentiated cell carcinoma (stage IVA). INTERVENTIONS: The patient received tislelizumab combined with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) nab-paclitaxel plus cisplatin for 4 cycles, followed by cisplatin-based concurrent chemoradiotherapy (CCRT). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The combination of tCSP and CSP further improved the system performance with an average accuracy of 84.77% and a peak accuracy of 100%. For dataset IVa in BCI competition III, the combination method got an average accuracy of 94.55%, which performed best among all the presented CSP-based methods. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…OBJECTIVES: The CSCO and ASCO guidelines in 2021 recommend chemotherapy for stage III–IVA (8th edition of AJCC staging) nasopharyngeal carcinoma (NPC). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…A subgroup analysis revealed that NAT was associated with improved OS and CSS among patients with stages III–IVA of the disease (OS: HR 0.65, 95%CI 0.46–0.92, p = 0.02, CSS: HR 0.62, 95%CI 0.41–0.92, p = 0.01). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The diseases in the 8 patients were: 4 mucopolysaccharidoses (MPS I two cases, IVA two cases), 1 Diamond-Blackfan anemia (DBA), 1 Fanconi anemia (FA), 1 hyperimmunoglobulin E syndrome (HIES), 1 Niemann-Pick disease. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: Between January 20 and November 2011, 498 consecutive NPC patients with stage I–IVA disease who received VMAT at a single center were retrospectively analyzed. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In subgroup analyses, only the patients in certain subgroups were found to benefit from adjuvant chemotherapy, such as patients who underwent right thoracotomy, pT3 diseases, pN1-pN3 diseases, or pTNM stage III and IVA diseases. CONCLUSIONS: Postoperative adjuvant chemotherapy can improve the OS and DFS of ESCC patients after radical resection but may only work for patients in certain subgroups.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Additionally, two complete mobile genomic islands coding for methicillin resistance SCCmec Iva (2B) were identified in strains S21 and S23. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Methods and material: In this prospective study, 46 patients with histologically proven stage III-IVA head and neck cancer were randomly assigned to receive either concurrent chemoradiation to a dose of 66 Gy in 33 fractions over 6.5 weeks with concurrent cisplatin (40 mg/m2 IV weekly; control arm) or accelerated radiotherapy with concomitant boost radiotherapy (study arm) to a dose of 67.5 Gy in 40 fractions in five weeks. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso